The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

Mr Birch's symptoms have "considerably eased" since starting the new injection For many years ... has late-onset asthma, which is harder to control with typical asthma medications than the asthma ...

MILLIONS of Brits with asthma are potentially risking their lives by not using their inhaler properly, UK experts have warned The UK has one worst death rates from the lung condition in ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that ... A recent trial finds an injection given during some asthma and COPD attacks is more ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast. The warnings are for users ...

The 60-year-old from Whixall, Shropshire, has late-onset asthma ... new injection has "considerably eased" Mr Birch's symptoms and although he still has to take some other forms of medication ...